Form 4: Zura Bio Ltd. Chief Technology Officer Granted Stock Options
SEC Form 4 Filing
Gary Whale, Chief Technology Officer of Zura Bio Ltd., reports the acquisition of employee share options.
Summary
- Gary Whale, the Chief Technology Officer of Zura Bio Ltd., filed a Form 4 on March 3, 2025, reporting a transaction.
- On February 27, 2025, Whale was granted employee share options for 302,000 Class A Ordinary Shares at an exercise price of $1.20.
- The options vest over time, with one-fourth vesting on February 27, 2026, and the remaining shares vesting in equal quarterly installments thereafter, contingent upon continuous service.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The granting of stock options is a positive sign of incentivizing management, but it's a routine event.
Positives
- The grant of stock options to the CTO aligns his interests with those of the shareholders.
- The vesting schedule incentivizes continued service and contribution to the company.
Future Outlook
The vesting schedule suggests a long-term commitment from the CTO.
Industry Context
Granting stock options to key executives is a common practice in the biotech industry to incentivize performance and align interests with shareholders.
Comparison to Industry Standards
- Stock option grants are a standard component of compensation packages for executives in publicly traded companies, particularly in the biotechnology sector.
- Vesting schedules typically range from three to five years, with quarterly or annual vesting increments, which aligns with the vesting schedule described in the document.
- The exercise price is typically set at or above the fair market value of the stock on the grant date.
Stakeholder Impact
- Shareholders may view the stock option grant as a positive incentive for the CTO.
- Employees may see this as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 02/27/2025 | Date of the transaction (grant of employee share options) |
| 02/27/2026 | First vesting date for the employee share options (1/4th of the shares) |
| 03/03/2025 | Date of Form 4 filing |
| 02/27/2035 | Expiration date of the employee share options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.